Sign in
8-K

Current Report

CytomX Therapeutics, Inc. Filed Acc 0001564590-18-024564

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading ctmx-8k_20181022.htm…